Hemispherx BioPharma Inc. (HEB) fell -8.02% or -0.02 to $0.24. It is approximately 362365 shares traded, which is 102.55% compare to the average total volume 353354. The market cap of HEB is $11.69 million. The year to date change is 35.27%. The 52 week price range is from $0.15 to $0.59. Price of HEB have changed 15.59% during last week. It have changed 45.66% over last month, 31.82% over last 3 months, -10.93% over last 6 months and -50.38% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HEB is 0.21. It is -12.50% below current price. The 200-day Moving Averages for HEB is 0.26. It is 8.33% above current price. The 52-week High is 0.59. It is 145.83% from the current price. The 52-week Low is 0.15. It is -37.50% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of HEB is 1.38 on 2019-01-15. Short % to float is 1.31%. There are some statistics of HEB. It is has market cap $11.69 million. The share outstanding is 48.19 million. The average volume is 353354. The percent of top 15 Institution holding is 5.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HEB is -124.34%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HEB is -68.48%.